Crossmark

Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay

Crossref DOI link: https://doi.org/10.1038/s41598-021-87331-7

Published Online: 2021-04-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

James, Nicholas G.

Malik, Shiazah

Sanstrum, Bethany J.

Rhéaume, Catherine

Broide, Ron S.

Jameson, David M.

Brideau-Andersen, Amy

Jacky, Birgitte S.
License Information

Text and Data Mining valid from 2021-04-09

Version of Record valid from 2021-04-09
More Information

Article History

Received: 12 June 2020

Accepted: 24 March 2021

First Online: 9 April 2021

Competing interests

: Dr. Jameson, Dr. James, and Bethany Sanstrum are Allergan (an AbbVie Company)-sponsored research collaborators. Shiazah Malik, Catherine Rheaume, Ron Broide, Amy Brideau-Andersen, and Birgitte S. Jacky are employees of Allergan plc (an AbbVie Company).

Document is current

Any future updates will be listed below